Literature DB >> 8671762

PCBs do not induce DNA breakage in vitro in human lymphocytes.

K Belpaeme1, K Delbeke, L Zhu, M Kirsch-Volders.   

Abstract

Polychlorinated biphenyls (PCBs) are classified by IARC as non-mutagenic in vivo. However, despite almost 20 years of research, their mutagenicity in vitro is still debatable. In this work the in vitro cytochalasin B micronucleus test and the alkaline comet assay applied to human lymphocytes were used to study the genotoxicity of a PCB. PCB77, at concentrations ranging from 0.01 to 100 microg/ml, was used in whole blood or isolated lymphocyte cultures, with final dimethylsulfoxide percentages of 0.5-2%. In the micro-nucleus test lymphocytes were exposed for 48 h, and in the alkaline comet assay for 30 min, 1 h and 3 h. No increases of single strand breaks or micronucleus frequencies was found, in contrast to previously reported data. Our data indicate that PCB77 has no clastogenic properties in human lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671762     DOI: 10.1093/mutage/11.4.383

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  3 in total

Review 1.  Polychlorinated biphenyls (PCBs) as initiating agents in hepatocellular carcinoma.

Authors:  Gabriele Ludewig; Larry W Robertson
Journal:  Cancer Lett       Date:  2012-12-02       Impact factor: 8.679

2.  2-(4'-CHLOROPHENYL)-1,4-BENZOQUINONE INCREASES THE FREQUENCY OF MICRONUCLEI AND SHORTENS TELOMERES.

Authors:  J A Jacobus; S Flor; A Klingelhutz; L W Robertson; G Ludewig
Journal:  Environ Toxicol Pharmacol       Date:  2008-03       Impact factor: 4.860

3.  Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodies.

Authors:  V Daniel; W Huber; K Bauer; C Suesal; C Conradt; G Opelz
Journal:  Environ Health Perspect       Date:  2001-02       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.